Institution
Fourth Affiliated Hospital of Harbin Medical University
Also known as: 哈尔滨医科大学第四附属医院
- 24running trials
- 23closed trials
- 4,780publications (OpenAlex)
Running trials
Not yet recruiting
Not yet recruiting
Recruiting
Non-stenting Treatment Strategy for Acute Myocardial Infarction With Non-severe Stenosis(EROSION IV)
Not yet recruiting
Active, not recruiting
A Study of Zovaglutide in Subjects With Overweight or Obesity (HORIZON-1)
Not yet recruiting
Left Ventricular Myocardial Work for Predicting Response to CRT
Active, not recruiting
Efficacy and Safety of ZT006 in Overweight and Obese Participants
Not yet recruiting
Recruiting
Efficacy and Safety of Orforglipron in Participants With Peripheral Artery Disease
Active, not recruiting
Not yet recruiting
Active, not recruiting
A Study of Orforglipron (LY3502970) in Participants With Obesity or Overweight and Type 2 Diabetes
Active, not recruiting
Active, not recruiting
Active, not recruiting
The Efficacy and Safety of Efsubaglutide Alfa Injection in Overweight and Obese Subjects (ENLIGHT)
Recruiting
TQC2731 Clinical Trial for the Treatment of Severe Asthma With Injection
Not yet recruiting
Effectiveness of Ginkgo Diterpene Lactone Meglumine in Acute Ischemic Stroke
Not yet recruiting
The Survey of Treatment and Metabolic Status of Type 1 Diabetes Mellitus (T1DM).
Recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Enrolling by invitation
A Follow-up Study of Peginterferon Alfa-2b Combined With TDF in Patients With Chronic Hepatitis B
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Heart failure2 recruiting
- Hepatitis B2 recruiting
- Obesity2 recruiting
- Asthma1 recruiting
- Colorectal cancer1 recruiting
- Coronary artery disease1 recruiting
- High blood pressure1 recruiting
- Liver and biliary tract cancer1 recruiting
- Neuromyelitis optica (NMOSD)1 recruiting
- Peripheral artery disease1 recruiting
- Pulmonary arterial hypertension1 recruiting
- Stroke1 recruiting
- Type 1 diabetes1 recruiting
Closed trials
Withdrawn
Completed
Completed
Phase II/III Clinical Trial of Recombinant Human Serum Albumin in Cirrhotic Patients With Ascites
Completed
A Study of ZT002 Injection With Subjects With Overweight or Obesity
Completed
To Evaluate Efficacy and Safety of HDM1002 Tablets in Adults With Type 2 Diabetes Mellitus
Completed
Completed
Completed
Efficacy and Safety of Berberine Ursodeoxycholate (HTD1801) in Patients With Type 2 Diabetes
Completed
A Study of HS-20094 Evaluating Weight Loss in Obese and Overweight Chinese Subjects
Completed
A Study of Tirzepatide (LY3298176) in Chinese Participants With Type 2 Diabetes (SURPASS-CN-MONO)
Completed
Completed
A Study to Evaluate the Efficacy and Safety of HRS9531 Injection in Obese Subjects Without Diabetes
Completed
A Study of Orforglipron in Adult Participants With Obesity or Overweight and Type 2 Diabetes
Completed
Completed
Efficacy and Safety of SPH3127 Tablets on Treating the Diabetic Kidney Disease
Completed
Terminated
A Phase II Clinical Trial of TQC3721 Suspension for Inhalation
Completed
Completed
Efficacy and Safety Study of Peginterferon Alfacon-2 to Treat Chronic Hepatitis B Virus Infection
Completed
Dual Anti-Platelet Therapy in Patients With Coronary Multi-Vessel Disease (DAPT-MVD)
Completed
Completed
A Study of Tirzepatide (LY3298176) in Participants With Obesity or Overweight
Completed
A Study of Peginterferon Alfa-2b Combined With TDF in Patients With Chronic Hepatitis B
Registry name variants (4)
Trial registries list this institution under these names. Each row is one registry entry: its address and the trials registered under it.
The Fourth Affiliated Hospital of Harbin Medical University
Harbin, 150001
39 trials
Harbin Medical University Affiliated Fourth Hospital
Harbin, Heilongjiang 150006
5 trials
The Fourth Affiliated Hospital Harbin Medical University
Harbin, Heilongjiang 150001
2 trials
Fourth Affiliated Hospital of Harbin Medical University
Harbin, Heilongjiang
1 trial
Institution data: ROR 02s7c9e98 (CC0-1.0)Updated 14 Nov 2026